港股異動 | 保利協鑫能源(3800.HK)連續第三日上漲 行業景氣度確定
格隆匯11月15日丨保利協鑫能源(3800.HK)再度拉昇漲5%,3日連漲近25%。報3.12港元,總市值781億港元。公司新增2萬噸硅烷流化牀法顆粒硅於11月10日正式投產。顆粒硅產品優良的碳足跡特性為公司客户推動全球“碳中和、碳達峯”目標提供了強而有力的支撐。本項目投產成功也驗證了公司顆粒硅經過十年研發及近一年的量產,在安全生產及環保健康方面得到保證。此前的半年報顯示,上半年淨利潤24.07億元,同比暴增220%。也就是説,在當下產業景氣度較為確定的背景下,2021年保利協鑫或創造近五年最好業績。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.